[Form 4] Factset Research Systems Insider Trading Activity

Rhea-AI Filing Summary

FactSet Research Systems Inc. (FDS) – Form 4 insider transaction

Director James J. McGonigle reported a same-day option exercise and sale on 14 July 2025:

• Options exercised: 2,010 shares at $271.51 and 915 shares at $318.20 (total 2,925 shares) stemming from 2020 and 2021 non-employee director grants.
• Shares sold: 2,925 shares in three open-market lots at weighted average prices of $449.93, $451.05 and $451.98, raising roughly $1.32 million.
• Post-transaction holding: 4,461 common shares held directly—unchanged from the level before the exercise/sale sequence.

The activity represents a routine cashless exercise where all shares obtained from the options were immediately sold. No new shares were added to, or removed from, the director’s long-term stake; therefore, the filing is viewed as neutral from a corporate-governance and liquidity standpoint and immaterial to FDS’s capital structure.

Insights

Equity Analyst

TL;DR: Routine cashless exercise; no change in insider ownership, minimal market impact.

The director exercised two tranches of fully-vested options (strike prices well below the $450 spot level) and liquidated the resulting shares, generating roughly $1.3 million in proceeds. Because the 2,925 shares sold exactly match the 2,925 acquired, beneficial ownership reverts to 4,461 shares—identical to the pre-transaction level. The volume represents less than 0.01 % of FDS’s outstanding shares and should not affect float or trading dynamics. Insider-sale signal risk is modest, as the transaction is typical end-of-option-cycle monetisation rather than outright reduction of an existing stake.

Corporate Governance Specialist

TL;DR: Governance-neutral filing; aligns with standard director compensation practices.

The options exercised were granted in 2020-2021 and vested on three-year anniversaries, consistent with FactSet’s equity-based compensation plan. Immediate sale implies a cash-settlement approach, common for outside directors who diversify rather than accumulate large positions. No red flags on timing or volume relative to blackout periods. Because ownership remains steady and no discretionary share disposals occurred, the event is governance-neutral and non-impactful for shareholder voting or compensation concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MCGONIGLE JAMES J

(Last) (First) (Middle)

C/O FACTSET RESEARCH SYSTEMS INC.

45 GLOVER AVENUE

(Street)

NORWALK CT 06850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FACTSET RESEARCH SYSTEMS INC [ FDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/14/2025		M		2,010	A	$271.51	6,471	D
Common Stock	07/14/2025		M		915	A	$318.2	7,386	D
Common Stock	07/14/2025		S		300	D	$449.93(1)	7,086	D
Common Stock	07/14/2025		S		1,200	D	$451.05(2)	5,886	D
Common Stock	07/14/2025		S		1,425	D	$451.98(3)	4,461	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Employee Director Stock Option (right to buy)	$271.51	07/14/2025		M			2,010	(4)	01/15/2027	Common Stock	2,010	$0	0	D
Non-Employee Director Stock Option (right to buy)	$318.2	07/14/2025		M			915	(5)	01/15/2028	Common Stock	915	$0	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades with sales prices ranging from $449.51 to $450.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This transaction was executed in multiple trades with sales prices ranging from $450.52 to $451.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades with sales prices ranging from $451.53 to $452.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. Options were granted January 15, 2020 and vested 100% upon the third anniversary of the date of grant.

5. Options were granted January 15, 2021 and vested 100% upon the third anniversary of the date of grant.

Remarks:

	/s/ JILL CHAVARRIA, Attorney in Fact for James J.McGonigle	07/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many FactSet (FDS) shares did director James McGonigle sell on 14 July 2025?

He sold 2,925 shares in three open-market transactions.

What was the total value of the shares sold based on the reported weighted average prices?

Approximately $1.32 million (2,925 shares × ≈$451 average price).

Did the director's ownership stake in FDS change after the transactions?

No. Beneficial ownership returned to 4,461 shares, the same level held before the option exercises.

What were the exercise prices of the options exercised?

Options were exercised at $271.51 (2,010 shares) and $318.20 (915 shares).

When were the exercised options originally granted and when do they expire?

The $271.51 options were granted 15 Jan 2020 (expire 15 Jan 2027); the $318.20 options were granted 15 Jan 2021 (expire 15 Jan 2028).